* PolyPid Ltd PYPD.OQ PYPD.O is expected to show no
change in
quarterly revenue when it reports results on May 10.
*
* Refinitiv's mean analyst estimate for PolyPid Ltd is for
a loss
of 26 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for PolyPid Ltd
is
$3, above its last closing price of $0.38.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.40 -0.41 -0.32 Beat 22.3
Sep. 30 2022 -0.55 -0.54 -0.48 Beat 11.2
Jun. 30 2022 -0.61 -0.62 -0.61 Beat 1.3
Mar. 31 2022 -0.65 -0.64 -0.63 Beat 1.6
Dec. -0.57 -0.56 -0.71 Missed -26.4
31 2021
Sep. 30 2021 -0.62 -0.62 -0.53 Beat 14.8
Jun. 30 2021 -0.55 -0.54 -0.56 Missed -3.7
Mar. 31 2021 -0.48 -0.50 -0.47 Beat 6
This summary was machine generated May 8 at 17:51 GMT. All
figures in US dollars unless otherwise stated